Enterprise Value
6.345M
Cash
156.4M
Avg Qtr Burn
-23.9M
Short % of Float
3.12%
Insider Ownership
37.70%
Institutional Own.
53.22%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
CNTY-101 Details Cancer, Relapsed/ refractory lymphoma | Phase 1 Data readout |